Öztürk M - Search Results

1

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry.

Martino M, Lanza F, Pavesi L, Öztürk M, Blaise D, Leno Núñez R, Schouten HC, Bosi A, De Giorgi U, Generali D, Rosti G, Necchi A, Ravelli A, Bengala C, Badoglio M, Pedrazzoli P, Bregni M; European Group for Blood and Marrow Transplantation Solid Tumor Working Party. Martino M, et al. Among authors: ozturk m. Biol Blood Marrow Transplant. 2016 Mar;22(3):475-81. doi: 10.1016/j.bbmt.2015.12.011. Epub 2015 Dec 23. Biol Blood Marrow Transplant. 2016. PMID: 26723932 Free article.

2

Serum chitotriosidase levels in cancer patients undergoing high dose chemotherapy and stem cell transplantation.

Ozturk M, Özkan E, Kesik V, Ozaydın S, Babacan O, Yaman H, Akgül EO, Kılıc S, Arpaci F, Ozet A, Kurt I, Demirbas S, Arslan E, Tok D. Ozturk M, et al. Eur Rev Med Pharmacol Sci. 2015 Sep;19(18):3433-7. Eur Rev Med Pharmacol Sci. 2015. PMID: 26439039 Free article.

3

Survival benefit with GM-CSF use after high-dose chemotherapy in high-risk breast cancer.

Kuzhan O, Ozet A, Ulutin C, Kömürcü S, Arpaci F, Oztürk B, Oztürk M. Kuzhan O, et al. Among authors: ozturk m, ozturk b. Tumori. 2007 Nov-Dec;93(6):550-6. doi: 10.1177/030089160709300606. Tumori. 2007. PMID: 18338488

4

The clinical significance of tumor cells in bone marrow or apheresis product and the efficacy of CD34+ selection and high-dose chemotherapy in patients with Stage III breast cancer.

Arpaci F, Safali M, Ozet A, Ural AU, Cetin T, Ozturk M, Ataergin S, Kuzhan O, Komurcu S, Ozturk B, Acikel C. Arpaci F, et al. Among authors: ozturk m, ozturk b. J Clin Apher. 2009;24(5):197-204. doi: 10.1002/jca.20211. J Clin Apher. 2009. PMID: 19816961 Clinical Trial.

5

Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.

Ataergin S, Arpaci F, Turan M, Solchaga L, Cetin T, Ozturk M, Ozet A, Komurcu S, Ozturk B. Ataergin S, et al. Among authors: ozturk m, ozturk b. Am J Hematol. 2008 Aug;83(8):644-8. doi: 10.1002/ajh.21206. Am J Hematol. 2008. PMID: 18508321 Free article. Clinical Trial.

6

Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation.

Ozturk M, Komurcu S, Kilic S, Ozet A, Arpaci F, Ozturk B, Kuzhan O, Ataergin S. Ozturk M, et al. Among authors: ozturk b. Support Care Cancer. 2009 Oct;17(10):1295-9. doi: 10.1007/s00520-009-0586-6. Epub 2009 Feb 6. Support Care Cancer. 2009. PMID: 19198890

7

Factors affecting engraftment time in autologous peripheral stem cell transplantation.

Turk HM, Komurcu S, Arpaci F, Ozet A, Kilic S, Kuzhan O, Ozturk B, Yilmaz I, Ataergin S, Ozturk M. Turk HM, et al. Among authors: ozturk m, ozturk b. Asian Pac J Cancer Prev. 2010;11(3):697-702. Asian Pac J Cancer Prev. 2010. PMID: 21039038 Free article.

8

Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.

Ataergin S, Ozet A, Solchaga L, Turan M, Beyzadeoglu M, Oysul K, Arpaci F, Komurcu S, Surenkok S, Ozturk M. Ataergin S, et al. Among authors: ozturk m. Med Oncol. 2009;26(3):276-86. doi: 10.1007/s12032-008-9115-6. Epub 2008 Nov 7. Med Oncol. 2009. PMID: 18989798

9

Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements.

Ocal N, Yildiz B, Karadurmus N, Dogan D, Ozaydin S, Ocal R, Ozturk M, Arpaci F, Bilgic H. Ocal N, et al. Among authors: ozturk m. Onco Targets Ther. 2016 Dec 9;9:7445-7450. doi: 10.2147/OTT.S107899. eCollection 2016. Onco Targets Ther. 2016. PMID: 28003760 Free PMC article.

10

Isolated renal relapse of a case with non-Hodgkin's lymphoma.

Turk HM, Ozet A, Ozturk M, Komurcu S, Kuzhan O, Arpaci F, Ozturk B, Safali M. Turk HM, et al. Among authors: ozturk m, ozturk b. Med Oncol. 2010 Jun;27(2):434-8. doi: 10.1007/s12032-009-9229-5. Epub 2009 May 13. Med Oncol. 2010. PMID: 19437146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,633 results

Search Page

Filters